{"id":480432,"date":"2023-12-10T19:19:02","date_gmt":"2023-12-11T03:19:02","guid":{"rendered":"https:\/\/nai500.com\/blog\/2023\/12\/%e9%87%8d%e5%a4%a7%e5%88%a9%e5%a5%bd%e5%85%91%e7%8e%b0-cf%e8%8d%af%e7%89%a9%e7%9a%84%e9%9c%b8%e4%b8%bb-%e5%ae%9e%e5%8a%9b\/"},"modified":"2023-12-10T19:19:21","modified_gmt":"2023-12-11T03:19:21","slug":"%e9%87%8d%e5%a4%a7%e5%88%a9%e5%a5%bd%e5%85%8c%e7%8f%be-cf%e8%97%a5%e7%89%a9%e7%9a%84%e9%9c%b8%e4%b8%bb-%e5%af%a6%e5%8a%9b","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2023\/12\/%e9%87%8d%e5%a4%a7%e5%88%a9%e5%a5%bd%e5%85%8c%e7%8f%be-cf%e8%97%a5%e7%89%a9%e7%9a%84%e9%9c%b8%e4%b8%bb-%e5%af%a6%e5%8a%9b\/","title":{"rendered":"\u91cd\u5927\u5229\u597d\u514c\u73fe\uff0cCF\u85e5\u7269\u7684\u9738\u4e3b\u7528\u884c\u52d5\u8b49\u660e\u4e86\u81ea\u5df1\u7684\u5be6\u529b"},"content":{"rendered":"<p>\u5927\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=VRTX\">\u798f\u6cf0\u88fd\u85e5Vertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09<\/a>\u5df2\u7d93\u5efa\u7acb\u4e86\u4e00\u500b\u5341\u5104\u7f8e\u5143\u898f\u6a21\u7684\u56ca\u6027\u7e96\u7dad\u5316\uff08CF\uff09\u6cbb\u7642\u85e5\u7269\u5e1d\u570b\uff0c\u4f46\u6295\u8cc7\u8005\u4e00\u76f4\u671f\u5f85\u8a72\u516c\u53f8\u80fd\u5920\u5be6\u73fe\u5176\u4ed6\u6cbb\u7642\u9818\u57df\u7684\u81ea\u6211\u7a81\u7834\uff0c\u84c4\u529b\u9577\u671f\u589e\u9577\u3002<\/p>\n<p>2020\u5e74\u548c2021\u5e74\uff0c\u798f\u6cf0\u88fd\u85e5\u7684\u5169\u6b3e\u6cbb\u7642\u03b11-\u6297\u80f0\u86cb\u767d\u9176\u7f3a\u4e4f\u75c7\uff08AATD\uff09\u7684\u5019\u9078\u85e5\u7269\u5ba3\u544a\u5931\u6557\uff0c\u80a1\u50f92021\u5e74\u6700\u4f4e\u9ede\u6642\u66b4\u8dcc\u7d0435%\u3002\u4e0d\u904e\u6700\u8fd1\uff0c\u8a72\u516c\u53f8\u806f\u5408CRISPR Therapeutics AG\uff08NASDAQ:CRSP\uff09\u958b\u767c\u7684\u942e\u72c0\u7d30\u80de\u75c5\uff08SCD\uff09\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5exa-cel\uff08\u5546\u54c1\u540dCasgevy\uff09\u7372\u6279\u4e0a\u5e02\u92b7\u552e\uff0c\u6295\u8cc7\u8005\u7684\u671f\u5f85\u4e5f\u7d42\u65bc\u7d50\u6210\u6b63\u679c\u3002<\/p>\n<h2>\u798f\u6cf0\u88fd\u85e5\uff1aCF\u9818\u57df\u7684\u9738\u4e3b<\/h2>\n<p>\u5148\u4f86\u8aaa\u8aaa\u798f\u6cf0\u88fd\u85e5\u7684\u56ca\u6027\u7e96\u7dad\u5316\u85e5\u7269\u3002\u8a72\u516c\u53f8\u6700\u66a2\u92b7\u7684\u85e5\u7269Trikafta\u7684\u5c08\u5229\u4fdd\u8b77\u671f\u5ef6\u7e8c\u81f32037\u5e74\uff0c\u540c\u6642\u5176\u4ed6\u7642\u6548\u66f4\u597d\uff0c\u7d66\u85e5\u66f4\u65b9\u4fbf\u7684CF\u5019\u9078\u85e5\u7269\u7684\u95dc\u9375\u8a66\u9a57\u4e5f\u5728\u9032\u884c\u4e2d\u3002\u6b64\u5916\uff0c\u91dd\u5c0d\u5269\u9918\u4e00\u5c0f\u90e8\u5206\u76ee\u524d\u7121\u85e5\u53ef\u91ab\u7684\u56ca\u6027\u7e96\u7dad\u5316\u60a3\u8005\uff0c\u8a72\u516c\u53f8\u806f\u624bModerna Inc.\uff08NASDAQ:MRNA\uff09\u555f\u52d5\u4e86\u5019\u9078\u85e5\u7269\u7684\u81e8\u5e8a\u8a66\u9a57\u3002\u53bb\u5e74\uff0cCF\u85e5\u7269\u70ba\u798f\u6cf0\u88fd\u85e5\u5275\u9020\u4e8689\u5104\u7f8e\u5143\u7684\u6536\u5165\uff0c\u5176\u4e2dTrikafta\u5360\u4e8687%\u3002<\/p>\n<p>\u518d\u4f86\u8aaa\u8aaaCasgevy\u3002\u7f8e\u570b\u6279\u51c6\u4e4b\u524d\u7684\u5e7e\u5468\uff0c\u82f1\u570b\u5168\u7403\u7b2c\u4e00\u500b\u6279\u51c6\u9019\u4e00\u57fa\u65bcCRISPR\u7684\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u6cbb\u7642\u942e\u72c0\u7d30\u80de\u548c\u03b2\u5730\u4e2d\u6d77\u8ca7\u8840\u3002\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u8a08\u5283\u660e\u5e743\u6708\u516c\u4f48Casgevy \u03b2\u5730\u4e2d\u6d77\u8ca7\u8840\u9069\u61c9\u75c7\u7684\u5be9\u6279\u6c7a\u5b9a\u3002\u6b64\u5916\uff0c\u6b50\u76df\u7684\u5be9\u6279\u6c7a\u5b9a\u4e5f\u5728\u9032\u884c\u7576\u4e2d\u3002Casgevy\u7684\u50f9\u683c\u96d6\u7136\u9ad8\u9054220\u842c\u7f8e\u5143\uff0c\u4f46\u7531\u65bc\u662f\u4e00\u6b21\u6027\u529f\u80fd\u6027\u6cbb\u7652\u65b9\u6848\uff0c\u56e0\u6b64\u4f9d\u7136\u5099\u53d7\u95dc\u6ce8\u3002<\/p>\n<h2>Casgevy\u5373\u5c07\u4e0a\u5e02<\/h2>\n<p>\u798f\u6cf0\u88fd\u85e5\u7684Casgevy\u99ac\u4e0a\u5c31\u5c07\u4e0a\u5e02\u92b7\u552e\uff0c\u4e26\u4e14\u5df2\u7d93\u5728\u7f8e\u570b\u8a2d\u7acb\u4e869\u5bb6\u6388\u6b0a\u6cbb\u7642\u4e2d\u5fc3\uff0c\u6f5b\u5728\u60a3\u8005\u4eba\u6578\u7d04\u70ba1.6\u842c\u3002\u6309\u7167\u9ad8\u76db\u7684\u9810\u6e2c\uff0cCasgevy\u7684\u5cf0\u503c\u6536\u5165\u70ba39\u5104\u7f8e\u5143\u3002FDA\u6279\u51c6\u4e4b\u5f8c\uff0c\u798f\u6cf0\u88fd\u85e5\u5c07\u5411CRISPR Therapeutics\u652f\u4ed82.00\u5104\u7f8e\u5143\u7684\u91cc\u7a0b\u7891\u6b3e\uff0c\u4e26\u4e14\u6309\u7167\u5206\u6210\u5354\u8b70\uff0c\u516c\u53f8\u5c07\u4fdd\u7559\u8a72\u7522\u54c160%\u7684\u5229\u6f64\u3002<\/p>\n<p>\u56e0\u6b64\uff0cCasgevy\u7684\u6536\u5165\u96d6\u7136\u7121\u6cd5\u9054\u5230CF\u7522\u54c1\u7d44\u5408\uff0c\u751a\u81f3\u662fTrikafta\u7684\u6c34\u5e73\uff0c\u4f46\u610f\u7fa9\u91cd\u5927\uff0c\u8aaa\u660e\u8a72\u516c\u53f8\u6709\u80fd\u529b\u62d3\u5c55\u65b0\u7684\u6536\u5165\u6e90\u3002\u6b64\u5916\uff0c\u798f\u6cf0\u88fd\u85e5\u7684\u5176\u4ed6\u975eCF\u7522\u54c1\u53ef\u80fd\u4e5f\u5c07\u5f88\u5feb\u9762\u4e16\u3002\u6bd4\u5982\u8aaa\uff0c\u8a72\u516c\u53f8\u5df2\u7d93\u5b8c\u6210\u4e86\u75bc\u75db\u7ba1\u7406\u5019\u9078\u7522\u54c1\u7684\u95dc\u9375\u8a66\u9a57\uff0c\u9810\u8a08\u660e\u5e74\u521d\u767c\u4f48\u7d50\u679c\u3002<\/p>\n<h2>\u80a1\u7968\u6027\u50f9\u6bd4\u5f88\u9ad8<\/h2>\n<p>\u96d6\u7136\u4eca\u5e74\u80a1\u50f9\u51fa\u73fe\u4e86\u5169\u4f4d\u6578\u7684\u4e0a\u6f32\uff0c\u4f46\u798f\u6cf0\u88fd\u85e5\u80a1\u7968\u76ee\u524d\u7684\u52d5\u614b\u5e02\u76c8\u7387\u4f9d\u7136\u53ea\u670923\u3002\u8003\u616e\u5230\u8a72\u516c\u53f8\u7a69\u5b9a\u7684\u5341\u5104\u7f8e\u5143\u7d1a\u5225\u7684\u76c8\u5229\u589e\u9577\uff0c\u8a72\u9818\u57df\u5167\u6301\u4e45\u7684\u7ba1\u7406\u5718\u968a\uff0c\u4ee5\u53ca\u73fe\u5728\u8a72\u516c\u53f8\u8b49\u660e\u81ea\u5df1\u6709\u80fd\u529b\u62d3\u5c55\u5176\u4ed6\u6cbb\u7642\u9818\u57df\uff0c\u9019\u4e00\u4f30\u503c\u6c34\u5e73\u7684\u6027\u50f9\u6bd4\u5f88\u9ad8\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5927\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8\u798f\u6cf0\u88fd\u85e5Vertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09\u5df2\u7d93\u5efa\u7acb\u4e86\u4e00\u500b\u5341 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":480430,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[809,2156,927,564],"class_list":["post-480432","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-809","tag-2156","tag-927","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/480432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=480432"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/480432\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/480430"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=480432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=480432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=480432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}